A new study from Kalorama reports that, in the coming years, antiallergy agents and gastrointestinal (GI) treatments are set to drive the US market for switching prescription drugs to OTC status,

 

作者: &NA;,  

 

期刊: PharmacoEconomics & Outcomes News Weekly  （ADIS Available online 2003）
卷期: Volume &NA;, issue 413  

页码: 12-12

 

ISSN:1173-5503

 

年代: 2003

 

出版商: ADIS

 

数据来源: ADIS

 

 

返 回